NCT03861702 - Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 2, 2020

Primary Completion Date

August 16, 2023

Study Completion Date

September 27, 2024

Conditions

Locally Advanced Pancreatic Carcinoma(LAPC)

Interventions

DRUG

FOLFOX regimen

FOLFOX (Oxaliplatin, Leucovorin, 5-Fluorouracil)

DRUG

Liposomal Irinotecan

Trial Locations (4)

Penn State Cancer Institute, Hershey

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis

Northwestern University Feinberg School of Medicine, Chicago

Rutgers Cancer Institute of new Jersey, New Brunswick